Methionine dependency and cancer treatment

Area of Science:

• Oncology
• Cancer Metabolism
• Nutritional Biochemistry

Background:

• Conventional chemotherapies face limitations in treating advanced cancers.
• Cancer cells exhibit metabolic abnormalities, presenting therapeutic targets.
• Many tumors demonstrate an essential requirement for the amino acid methionine.

Purpose of the Study:

• To explore methionine dependency in cancer cells as a therapeutic strategy.
• To evaluate methods for reducing methionine levels in vivo for cancer treatment.
• To investigate the potential of methionine restriction as an adjunct to chemotherapy.

Main Methods:

• Utilizing methionine-free diets or total parenteral nutrition to restrict methionine.
• Employing the enzyme methioninase for targeted methionine depletion.
• Assessing tumor regression in animal models.
• Examining the synergistic effects of methionine restriction with chemotherapeutic agents in preclinical studies.

Main Results:

• Methionine restriction, via diet or methioninase, induced regression in various animal tumors.
• Methionine depletion using methioninase inhibited tumor growth in preclinical models.
• Preclinical studies indicated synergy between methionine restriction and cytotoxic chemotherapy drugs.

Conclusions:

• Methionine dependency represents a viable target for cancer therapy.
• While prolonged methionine restriction has limitations for clinical use, its combination with chemotherapy is promising.
• Methionine restriction, particularly when combined with chemotherapy, could serve as an effective additional cancer therapeutic strategy.